THC Farmaceuticals, Inc. (CBDG)
OTCMKTS · Delayed Price · Currency is USD
0.0171
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
THC Farmaceuticals Revenue
THC Farmaceuticals had revenue of $4.50K in the quarter ending June 30, 2015, with 3.04% growth. This brings the company's revenue in the last twelve months to $18.52K, down -1.50% year-over-year. In the fiscal year ending September 30, 2014, THC Farmaceuticals had annual revenue of $19.03K, down -12.04%.
Revenue (ttm)
18.52K
Revenue Growth
-1.50%
P/S Ratio
16.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
310.05K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2014 | 19.03K | -2.61K | -12.04% |
| Sep 30, 2013 | 21.64K | -8.94K | -29.23% |
| Sep 30, 2012 | 30.58K | -3.58K | -10.48% |
| Sep 30, 2011 | 34.16K | -4.03K | -10.55% |
| Sep 30, 2010 | 38.19K | -1.93K | -4.80% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Regenerative Medical Technology Group | 5.04M |
| Hemagen Diagnostics | 4.04M |
| Helix BioMedix | 2.07M |
| Endonovo Therapeutics | 255.72K |
| GB Sciences | 97.24K |
| CNBX Pharmaceuticals | 40.64K |
| Oncology Pharma | 10.21K |
THC Farmaceuticals News
- 4 years ago - Legendary Hero Senator Mike Gravel Ended Final Career As Chairman and CEO of THC Farmaceuticals, Inc When He Passed Away This Weekend - GlobeNewsWire